Future trends in islet cell transplantation

Diabetes Technology and Therapeutics

Volumn 2, Issue 3, 2000, Pages 449-452

  Shapiro, A M J ^a   Lakey, J R T ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNE DISEASE; CELL CLONING; CELL FUNCTION; CELL MATURATION; CELL TRANSPLANTATION; CLINICAL PROTOCOL; FOLLOW UP; GRAFT REJECTION; HUMAN; INSULIN DEPENDENCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN SYNTHESIS; NOTE; PANCREAS ISLET CELL; PRIORITY JOURNAL; RECURRENT DISEASE; REGISTER; SAFETY;

ANIMALS; DIABETES MELLITUS, TYPE 1; GRAFT SURVIVAL; HUMANS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; STEM CELLS; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0033768699     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/15209150050194314     Document Type: Note

References (36)

1. Successful islet transplantation for patients with diabetes - Fact or fantasy?
2. Islet Transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen
3. Diabetogenic synergism in canine islet autografts from cyclosporine and steroids in combination
4. Portal vein immunosuppressant levels and islet graft toxicity
5. Islet transplantation for patients with type 1 diabetes
6. Sensitization to HLA antigens in islet recipients with failing transplants
7. Reversal of lesions of diabetic nephropathy after pancreas transplantation
8. Long-term effects of pancreatic transplantation on diabetic neuropathy
9. Improved survival in patients with insulin-dependent diabetes mellitus and end-stage diabetic nephropathy 10 years after combined pancreas and kidney transplantation
10. Nine year islet allograft function in patients with type 1 DM
11. Prevention of diabetes for up to 13 years by autoislet transplantation after pancreatectomy for chronic pancreatitis
12. Sirolimus-tacrolimus combination immunosuppression
13. Modulation of humoral islet autoimmunity by pancreas allotransplantation influences allograft outcome in patients with type 1 diabetes
14. Islet cell damage associated with tacrolimus and cyclosporine: Morphological features in pancreas allograft biopsies and clinical correlation
15. Can diabetic neuropathy be prevented by angiotensin-converting enzyme inhibitors?
16. Damage to porcine islets of Langerhans after exposure to human blood in vitro, or after intraportal transplantation to cynomologus monkeys: Protective effects of sCR1 and heparin
17. Incompatibility between human blood and isolated islets of Langerhans: A finding with implications for clinical intraportal islet transplantation?
18. Comparison of harvesting methods for islet transplantation
19. Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154
20. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates
21. Platelets and cytokines in concert with endothelial activation in patients with peripheral arterial occlusive disease
22. Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance
23. Rapamune (RAPA, rapamycin, sirolimus): Mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression
24. Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance
25. Liver-islet transplantation in type 2 diabetes
26. Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: Economic analysis alongside randomised controlled trial (UKPDS 41). United Kingdom Prospective Diabetes Study Group
27. Cost-effectiveness of intensive insulin therapy for type 2 diabetes: A 10-year follow-up of the Kumamoto study
28. In vitro cultivation of human islets from expanded ductal tissue
29. Can we create new organs from our own tissues?
30. Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells
31. Cloning and sequencing of the pancreatic islet neogenesis associated protein (INGAP) gene and its expression in islet neogenesis in hamsters
32. Accelerated telomere shortening and senescence in human pancreatic islet cells stimulated to divide in vitro
33. Towards gene therapy of diabetes mellitus
34. Infection of nonhuman primate cells by pig endogenous retrovirus
35. Life supporting function for over one month of a transgenic porcine heart in a baboon